IDH1 mutant negative ganglioglioma progression to gliosarcoma

Gangliogliomas comprise of less than 1% of all primary brain tumours. Malignant transformation is rare. Correspondingly, secondary gliosarcomas, especially in the absence of previous irradiation exposure is too, exceedingly rare. Recent evidence supports the use of mutant IDH1 testing in suspected a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Liming Qiu, Yee Lin Tang, Nicolas K.K. King, Khoon Leong Chuah, Siang Hui Lai, Keith H.C. Lim, Wai Hoe Ng, Sharon YY Low
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier 2017-09-01
Cyfres:Interdisciplinary Neurosurgery
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S2214751916300809
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg